Correlation Between Sarepta Therapeutics and Ultragenyx
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Ultragenyx, you can compare the effects of market volatilities on Sarepta Therapeutics and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Ultragenyx.
Diversification Opportunities for Sarepta Therapeutics and Ultragenyx
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sarepta and Ultragenyx is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Ultragenyx go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Ultragenyx
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 1.48 times more return on investment than Ultragenyx. However, Sarepta Therapeutics is 1.48 times more volatile than Ultragenyx. It trades about 0.09 of its potential returns per unit of risk. Ultragenyx is currently generating about -0.15 per unit of risk. If you would invest 12,489 in Sarepta Therapeutics on August 31, 2024 and sell it today you would earn a total of 1,305 from holding Sarepta Therapeutics or generate 10.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sarepta Therapeutics vs. Ultragenyx
Performance |
| Timeline |
| Sarepta Therapeutics |
| Ultragenyx |
Sarepta Therapeutics and Ultragenyx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarepta Therapeutics and Ultragenyx
The main advantage of trading using opposite Sarepta Therapeutics and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
| Ultragenyx vs. X4 Pharmaceuticals | Ultragenyx vs. Terns Pharmaceuticals | Ultragenyx vs. Day One Biopharmaceuticals | Ultragenyx vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |